Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

CYPHERPUNK TECHNOLOGIES INC.

CYPH · Nasdaq · CIK 0001509745 · Healthcare · Asset Management

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

7 Form 4 transaction lines observed in the same window
3 sales · 4 option, withholding, award, gift or other lines

Last qualifying purchase2021-09-24 · BeiGene, Ltd. · $7.2M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
McEvoy William Patrick IIIChief Investment Officer
○○
Winklevoss Cameron Howard; Winklevoss Capital Fund, LLC; Winklevoss Capital Management, LLC; Winklevoss Treasury Investments, LLC; Winklevoss Tyler HowardTenPercentOwner
○○
Oei Khing DjienDirector
▼
Martin Patricia A.Director
▼
Dietz Thomas JohnDirector
▼
● Purchase▼ Sale○ Other

—

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2021-09-24 · BeiGene, Ltd..

Recent Form 4 activity

0Purchases
9Sales
29Other Form 4 lines
24SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING3 sale line(s) · context only
OTHER4 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
13,447,367
Previous report
9,853,398
Avg daily volume
22,275,542
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2021-09-24BeiGene, Ltd.Purchase (P)Common Stock2,543,800USD 2.85USD 7,249,830SEC filing ↗
2020-06-22EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock1,750,000USD 2.00USD 3,500,000SEC filing ↗

Form 4 evidence

38 transaction lines in the latest 365-day window; 62 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-12Winklevoss Cameron Howard; Winklevoss Capital Fund, LLC; Winklevoss Capital Management, LLC; Winklevoss Treasury Investments, LLC; Winklevoss Tyler HowardX (X)Common Stock4,938,801USD 0.00USD 4,939SEC filing ↗
2026-10-12McEvoy William Patrick IIIX (X)Common Stock4,938,801USD 0.00USD 4,939SEC filing ↗
2026-09-25Oei Khing DjienSale (S)Common Stock168,750USD 3.92USD 661,500SEC filing ↗
Show recent Form 4 evidence (25 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-12Winklevoss Cameron Howard; Winklevoss Capital Fund, LLC; Winklevoss Capital Management, LLC; Winklevoss Treasury Investments, LLC; Winklevoss Tyler HowardX (X)Common Stock4,938,801USD 0.00USD 4,939SEC filing ↗
2026-10-12McEvoy William Patrick IIIX (X)Common Stock4,938,801USD 0.00USD 4,939SEC filing ↗
2026-09-25Oei Khing DjienSale (S)Common Stock168,750USD 3.92USD 661,500SEC filing ↗
2026-09-23Martin Patricia A.Sale (S)Common Stock50,000USD 3.86USD 193,000SEC filing ↗
2026-08-26Dietz Thomas JohnSale (S)Common Stock20,000USD 1.72USD 34,400SEC filing ↗
2026-08-17Winklevoss Cameron Howard; Winklevoss Capital Fund, LLC; Winklevoss Capital Management, LLC; Winklevoss Treasury Investments, LLC; Winklevoss Tyler HowardX (X)Common Stock16,570,852USD 0.00USD 0SEC filing ↗
2026-08-17McEvoy William Patrick IIIX (X)Common Stock16,570,852USD 0.00USD 0SEC filing ↗
2026-03-26Mirabelli ChristopherSale (S)Common Stock60,000USD 0.71USD 42,600SEC filing ↗
2026-03-13Schilsky RichardOption exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2026-03-13Richard Christian MOption exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2026-03-13Oei Khing DjienOption exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2026-03-13Mirabelli ChristopherOption exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2026-03-13Mashiach NissimOption exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2026-03-13Martin Patricia A.Option exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2026-03-13LOSCALZO JOSEPHOption exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2026-03-13LI WILLIAMOption exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2026-03-13Dietz Thomas JohnOption exercise / conversion (M)Common Stock104,500USD —USD —SEC filing ↗
2026-03-13CAVANAUGH JAMES HOption exercise / conversion (M)Common Stock168,750USD —USD —SEC filing ↗
2025-12-26Dietz Thomas JohnOption exercise / conversion (M)Common Stock83,000USD —USD —SEC filing ↗
2025-12-26Dietz Thomas JohnTax withholding (F)Common Stock35,000USD 1.20USD 42,000SEC filing ↗
2025-12-23ONSI DOUGLAS EJ (J)Common Stock2,848USD 0.00USD 0SEC filing ↗
2025-12-23Mirabelli ChristopherJ (J)Common Stock2,848USD 0.00USD 0SEC filing ↗
2025-11-17ONSI DOUGLAS ESale (S)Common Stock676,319USD 3.14USD 2,123,642SEC filing ↗
2025-11-17Mirabelli ChristopherSale (S)Common Stock676,319USD 3.14USD 2,123,642SEC filing ↗
2025-11-17CAVANAUGH JAMES HSale (S)Common Stock261,840USD 3.14USD 822,178SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCYPH
CIK0001509745
SectorHealthcare
IndustryAsset Management Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history62 transaction lines from 2020-06-22 to 2026-10-12
2 P purchase lines · 9 S sale lines · 51 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.